3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Whooping Cough
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumococcal Infections
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Measles
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Hepatitis B
1
HIV Infections
1
Interventions
Cyclophosphamide
21
Cyclosporine
14
fludarabine phosphate
13
Whole-Body Irradiation
13
Peripheral Blood Stem Cell Transplantation
13
Filgrastim
10
Rituximab
9
Mycophenolic Acid
9
Antilymphocyte Serum
9
Radiotherapy
7
Methotrexate
7
Busulfan
7
Melphalan
6
Psychiatric Rehabilitation
5
Etoposide
5
Dexamethasone
5
Cytarabine
5
Aprepitant
5
fludarabine
4
Vincristine
4
Ondansetron
4
Methylprednisolone
4
Granulocyte Colony-Stimulating Factor
4
Doxorubicin
4
Cord Blood Stem Cell Transplantation
4
plerixafor
3
Zidovudine
3
Therapeutics
3
Stem Cell Transplantation
3
Prednisone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, Non-Hodgkin
×
Tetanus Toxoid
×
Clear all
NCT01611298
2020-04-21
TAR
Baylor College of Medicine
Phase NA
Completed
7 enrolled
8 charts